NEW YORK (GenomeWeb News) — Results of an ongoing collaboration between Lumera and the Harvard Institute of Proteomics have enabled the partners to try to use Lumera’s ProteomicProcessor biosensor to develop new diagnostics.
Since January, Harvard has served as a beta site for Lumera's platform. Researchers there have been trying to enable the ProteomicProcessor to analyze data from, their nucleic acid programmable protein array technology, also known as NAPPA.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

Sponsored by

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.